Targeting Epigenetic Regulators in Cancer to Overcome Resistance to Targeted Therapy
- 16 July 2019
- book chapter
- Published by Springer Nature
- p. 259-289
Abstract
No abstract availableKeywords
This publication has 163 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic LeukemiaJAMA, 2011
- The histone variant macroH2A suppresses melanoma progression through regulation of CDK8Nature, 2010
- Out of Africa and into epigenetics: discovering reprogramming drugsNature Cell Biology, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Epigenetics in cancerCarcinogenesis, 2009
- Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinibDrug Resistance Updates, 2009
- Decitabine and its role in the treatment of hematopoietic malignanciesLeukemia & Lymphoma, 2007
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005
- The Role of DNA Methylation in Mammalian EpigeneticsScience, 2001